Skip to main content
STTK logo

Shattuck Labs, Inc.

STTKNASDAQHealthcareBiotechnology

$5.54Today:- (-)1Y +202.70%

As of Oct 26, 2026 close

Market cap
$718.98M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$1.72$8.33
Volume (live)
-
Avg. volume (3M)
1.47M

Shattuck Labs (STTK) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Shattuck Labs used $39.88M of cash in operating activities and spent $71.00K on capital expenditures. That left free cash flow of −$39.95M.

Shattuck Labs Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Shattuck Labs, Inc. (STTK) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-48.81-75.41-87.30-101.95-44.97-36.60-23.98-7.39
Depreciation & Amortization3.693.834.043.071.380.620.540.26
Deferred Income Tax0.000.000.000.003.040.000.00-0.40
Stock Based Compensation7.009.556.946.465.471.270.460.43
Change in Working Capital-0.793.02-4.10-4.46-23.551.062.22-2.50
Change in Accounts Payable-0.320.83-5.63-2.847.87-1.751.001.12
Change in Other Working Capital-0.605.561.53-1.62-31.41-3.761.21-3.62
Other Operating Activities-0.60-1.50-0.822.381.520.00-0.212.71
Net Cash from Operating Activities-39.88-60.52-81.23-94.50-57.12-33.66-20.98-6.90
Investing Activities
Capital Expenditures-0.07-0.06-0.41-11.61-7.93-0.73-0.47-1.18
Acquisitions0.000.000.000.102.52145.600.000.00
Purchases of Investments-43.42-93.55-79.73-132.38-204.09-145.60-44.27-28.73
Sales/Maturities of Investments35.6085.10191.00193.33201.5837.6041.150.00
Other Investing Activities0.000.000.000.00-2.52-145.600.00-0.02
Net Cash from Investing Activities-7.89-8.51110.8649.44-10.44-146.32-3.59-29.93
Financing Activities
Common Stock Issued44.481.2448.670.171.93232.530.0035.15
Common Stock Repurchased0.00-0.470.000.000.000.000.000.00
Other Financing Activities-0.07-0.45-0.050.000.00-19.28-0.0635.15
Net Cash from Financing Activities44.570.7948.620.171.93330.87-0.0635.15
Summary
Net Change in Cash-3.20-68.2478.25-44.89-65.63150.89-24.63-1.68
Cash at Beginning of Period57.39125.6347.3892.27157.907.0131.6433.33
Cash at End of Period54.1957.39125.6347.3892.27157.907.0131.64
Free Cash Flow-39.95-60.57-81.64-106.11-65.04-34.39-21.45-8.08

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Shattuck Labs Cash Flow

What is Shattuck Labs's free cash flow?

Shattuck Labs had negative free cash flow of $39.95M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$39.88M minus $71.00K of capital expenditures.

How much does Shattuck Labs spend on capital expenditures?

Shattuck Labs spent $71.00K on capital expenditures in fiscal 2025, compared with $59.00K a year earlier.

Does Shattuck Labs pay dividends or buy back shares?

Shattuck Labs's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition